去年，NextPlat Corp表现最佳的业务板块Pharmacy Prescription And Other Revenue Net Of Pbm Fees实现营收35.70M美元。Europe的营收贡献最高，去年达到7.45M美元。最近一个季度，截至2026-06-30，NextPlat Corp表现最佳的业务板块Pharmacy Prescription And Other Revenue Net Of Pbm Fees实现营收5.56M美元。Europe的营收贡献最高，达到2.31M美元。

业务

营业收入

占比

年报

年报

单季报

Pharmacy Prescription And Other Revenue Net Of Pbm Fees

e-Commerce revenue

Pharmacy 340B contract revenue

Eliminations

FY2025

FY2024

FY2023

Pharmacy Prescription And Other Revenue Net Of Pbm Fees

35.70M(65.73%)

41.91M(63.42%)

21.41M(56.71%)

e-Commerce revenue

14.61M(26.89%)

13.79M(20.87%)

10.98M(29.07%)

Pharmacy 340B contract revenue

4.01M(7.38%)

10.38M(15.71%)

5.37M(14.21%)

Eliminations

--(--)

地区

营业收入

占比

年报

年报

单季报

Europe

North America

Asia & Pacific

Africa

South America

FY2025

FY2024

FY2023

FY2022

FY2021

Europe

7.45M(51.01%)

6.81M(49.39%)

6.69M(60.92%)

8.62M(73.59%)

5.15M(66.49%)

North America

4.68M(32.06%)

4.53M(32.84%)

2.58M(23.46%)

2.15M(18.37%)

1.78M(22.95%)

Asia & Pacific

1.97M(13.47%)

1.72M(12.47%)

1.51M(13.76%)

760.45K(6.49%)

695.77K(8.99%)

Africa

462.00K(3.16%)

683.00K(4.95%)

143.00K(1.30%)

136.05K(1.16%)

84.38K(1.09%)

South America

44.00K(0.30%)

47.00K(0.34%)

62.00K(0.56%)

45.03K(0.38%)

37.14K(0.48%)